Trial intelligence / Profile preview

Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients

NCT07175623Completed

Sponsor
Konya City Hospital
Start
Sep 2025
Primary completion
Dec 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, triple-blind trial in postoperative nausea and vomiting (PONV) and postoperative pain comparing Methylprednisolone 1 mg/kg, Dexamethasone 0.2 mg/kg and Placebo (3 arms). Primary endpoint: Time to recovery of neuromuscular function (normalized TOF ratio >= 0.9). Started Sep 2025; status: completed.

02

Drugs

methylprednisolone injectiondexamethasone
03

Conditions

postoperative nausea and vomiting (PONV)postoperative pain

Beyond the preview

Go deeper on NCT07175623.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07175623.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call